logo
Anthem Biosciences IPO listing date today. GMP, analysts signal strong debut of shares in stock market today

Anthem Biosciences IPO listing date today. GMP, analysts signal strong debut of shares in stock market today

Mint13 hours ago
Anthem Biosciences IPO Listing: Anthem Biosciences shares are set to make their debut in the Indian stock market today. The initial public offering (IPO) of specialized fermentation-based APIs manufacturer received stellar demand during its subscription period, and Anthem Biosciences IPO listing date is today.
The public issue was open from July 14 to July 16, and Anthem Biosciences IPO allotment date was July 17. Anthem Biosciences IPO listing date is today, 21 July 2025. Anthem Biosciences shares will be listed today on both the stock exchanges, BSE and NSE.
'Trading Members of the Exchange are hereby informed that effective from Monday, July 21, 2025, the equity shares of Anthem Biosciences Limited shall be listed and admitted to dealings on the Exchange in the list of 'B' Group of Securities,' a notice on the BSE said.
Anthem Biosciences shares will be a part of Special Pre-open Session (SPOS) on Monday, July 21, 2025, it added, and the stock will be available for trading from 10:00 AM.
Ahead of Anthem Biosciences IPO listing today, investors watch out for the trends in grey market premium (GMP) in order to gauge the estimated listing price of the shares.
Anthem Biosciences IPO GMP today and analysts signal a strong debut of shares in the Indian stock market today. Here's what Anthem Biosciences IPO GMP indicates:
The trends for Anthem Biosciences shares in the unlisted market remains bullish with a strong grey market premium. According to stock market experts, Anthem Biosciences IPO GMP today is ₹ 177 per share. This indicates that Anthem Biosciences shares are available at a premium of ₹ 177 apiece in the grey market than their issue price of ₹ 570 per share.
Anthem Biosciences IPO GMP today signals that the estimated Anthem Biosciences share listing price would be ₹ 747 apiece, which is at a 31.05% premium to the IPO price of ₹ 570 per share.
Analysts also expect Anthem Biosciences shares to list at a strong premium to its issue price on the stock exchanges.
'Anthem Biosciences is expected to make a strong debut on the stock exchanges. Given the robust investor demand during the IPO particularly from institutional investors, the shares suggest a potential listing in the range of ₹ 700 or higher, translating into a premium of around 20–25%,' said Mahesh M. Ojha, AVP - Research & Business Development, Hensex Securities Pvt. Ltd..
According to him, from a fundamentals perspective, a premium listing appears reasonable.
Harshal Dasani Business Head, INVasset PMS, noted that over the weekend, Anthem Biosciences IPO GMP rose further to ₹ 165–170, indicating a likely listing price of ₹ 735–740, or a listing gain of approximately 29%.
'This level of interest reflects extraordinary investor conviction and places Anthem in an elite bracket of biotech listings in India. With no fresh issue component, there is zero dilution and no pressure to deploy new capital. If Q2 earnings keep pace and listing trends match market buzz, Anthem Biosciences could well position itself as the poster child of India's biotech resurgence,' said Dasani.
The bidding for the Anthem Biosciences IPO opened on Monday, July 14, and closed on Wednesday, July 16. The IPO allotment date was July 17, and the Anthem Biosciences IPO listing date is today, 21 July 2025. Anthem Biosciences shares will be listed on BSE and NSE.
The ₹ 3,395.00-crore Anthem Biosciences IPO was entirely an offer-for-sale (OFS) of 5.96 crore equity shares, issued at a fixed IPO price band of ₹ 570 per share.
Anthem Biosciences IPO was subscribed 63.86 times in total, as per the NSE subscription data. The retail portion was booked 5.64 times, while the Non Institutional Investors (NII) segment was subscribed 42.36 times. The Qualified Institutional Buyers (QIBs) category received 182.65 times subscription.
JM Financial is the book-running lead manager of the Anthem Biosciences IPO, while Kfin Technologies is the registrar for the issue.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Super League Kerala signs five-year Rs 100-crore streaming rights deal with Sports.com
Super League Kerala signs five-year Rs 100-crore streaming rights deal with Sports.com

The Hindu

time21 minutes ago

  • The Hindu

Super League Kerala signs five-year Rs 100-crore streaming rights deal with Sports.com

a part of the USA-based SEGG Media Group, has signed a five-year global partnership with Super League Kerala that could increase the football league's viewership in a big way. 'This is a Rs 100-crore deal and the contract is for five years. The global live streaming rights are now with Mathew Joseph, the CEO of the Super League Kerala (SLK), told Sportstar on Monday. 'This is also first entry into India; it will become the exclusive OTT platform for the SLK, and it will be free of cost. That is what we are more interested in,' he added. Joseph revealed that the deal, signed in Dubai, will also help build more content around the SLK, which attracted nearly 13 million viewers for its debut season last year. ALSO READ | VP Suhair set to join Jamshedpur FC ahead of Durand Cup 'They will also help us with content creation around the SLK which they have done globally for many sports…behind the scenes, they create a lot of interesting documentaries,' said Joseph. 'This deal represents a huge leap forward for the SLK. It allows us to amplify our reach across continents while delivering world-class fan engagement and streaming experiences to millions who love Kerala football,' said Firoz Meeran, Director, SLK. 'This is more than a sports rights deal. To enter the Indian market through Kerala, a State with an electrifying football culture and millions of global fans, gives us a high-growth, cash-yielding product to launch the app with force,' Firoz added. Related Topics Super League Kerala

Bharat NCX 2025 commences to bolster Indias cybersecurity preparedness
Bharat NCX 2025 commences to bolster Indias cybersecurity preparedness

Mint

time27 minutes ago

  • Mint

Bharat NCX 2025 commences to bolster Indias cybersecurity preparedness

New Delhi [India], July 21 (ANI): The National Cybersecurity Exercise - Bharat NCX 2025 was officially inaugurated on Monday with the aim to strengthen India's cyber defence posture. The Bharat NCX 2025 was inaugurated by Deputy National Security Advisor T. V. Ravichandran, in the presence of Bimal N. Patel, Vice Chancellor of Rashtriya Raksha University (RRU). It was organised by the National Security Council Secretariat (NSCS) in collaboration with RRU. According to the statement by NSCS, the event was held under the theme Enhancing the Operational Preparedness of Indian Cyberspace. The two-week national-level cyber drill brings together cybersecurity professionals, defence personnel, policymakers, and industry leaders. The initiative is designed to simulate complex real-world cyber incidents, including attacks on critical infrastructure, deepfake threats, API vulnerabilities, and autonomous malware scenarios. In his keynote address, Ravichandran emphasised that cybersecurity of our digital infrastructure underpins to national security, economic growth, and public safety. From governance and healthcare to energy, transportation, and defence, the cybersecurity of our digital infrastructure underpins national security, economy, citizen trust and public safety," he said, highlighting the value of realistic and high-impact cyber simulations like Bharat NCX. Delivering the special address, Patel also stated that Cyber and AI capabilities have emerged as a potent tool of cyber defence, and digital space has evolved into a novel arena for statecraft, competition, and conflict, involving nation states and state-sponsored actors. He outlined important objectives such as proactively preventing cyber-attacks, lowering the country's susceptibility to cyber threats, and accelerating recovery with minimal impact when incidents occur. Key features of Bharat NCX 2025 include live-fire cyber simulations, an AI-integrated cybersecurity framework, a Strategic Decision-Making Exercise (STRATEX) for senior leaders, and a CISO Conclave featuring key government and industry cybersecurity officers. Additionally, the Bharat Cybersecurity Startup Exhibition will showcase innovative Indian solutions for building a secure and self-reliant digital infrastructure. Running from July 21 to August 1, the exercise will conclude with a comprehensive debriefing to consolidate insights, refine national cyber strategies, and strengthen collective resilience. (ANI)

Jane Street Reenters Indian Markets After $567 Million Deposit: Sources
Jane Street Reenters Indian Markets After $567 Million Deposit: Sources

NDTV

time29 minutes ago

  • NDTV

Jane Street Reenters Indian Markets After $567 Million Deposit: Sources

India's markets regulator has allowed Jane Street to restart trading after the US high-frequency trading firm deposited $567 million, two sources aware of the matter said on Monday. The regulator sent an email to the firm on Friday in which it said that following the deposit of the money, the restrictions imposed by its interim order are no longer applicable, said the sources, who declined to be named because they are not authorised to speak to the media. In an interim order issued on July 3, the Securities and Exchange Board of India (SEBI) had barred the firm from buying and selling securities in the Indian market and froze $567 million of its funds. Jane Street could resume trading if an equivalent amount was deposited in an account that gives the regulator rights over the money until its investigation is complete, the order stated. Email queries sent to Jane Street and SEBI were not answered immediately. The country's stock exchanges, the National Stock Exchange of India Ltd and BSE Ltd, have been directed to closely monitor the activity of the US-based quant trading firm, the sources said. The two exchanges are yet to facilitate Jane Street's buying and selling of Indian securities, said one of the sources. "While the firm has been allowed to resume trading in India, it has given an undertaking to SEBI that it will not trade in options. The firm also does not intend to trade in cash till it has explained its trades to SEBI," the second source said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store